Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease

Lorraine V. Kalia, Anthony E. Lang, Lili Naz Hazrati, Shinsuke Fujioka, Zbigniew K. Wszolek, Dennis W. Dickson, Owen A. Ross, Vivianna M. Van Deerlin, John Q. Trojanowski, Howard I. Hurtig, Roy N. Alcalay, Karen S. Marder, Lorraine N. Clark, Carles Gaig, Eduardo Tolosa, Javier Ruiz-Martínez, Jose F. Marti-Masso, Isidre Ferrer, Adolfo López De Munain, Samuel M. GoldmanBirgitt Schüle, J. William Langston, Jan O. Aasly, Maria T. Giordana, Vincenzo Bonifati, Andreas Puschmann, Margherita Canesi, Gianni Pezzoli, Andre Maues De Paula, Kazuko Hasegawa, Charles Duyckaerts, Alexis Brice, A. Jon Stoessl, Connie Marras

Research output: Contribution to journalArticle

123 Scopus citations

Abstract

IMPORTANCE: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of genetic Parkinson disease (PD) known to date. The clinical features of manifesting LRRK2 mutation carriers are generally indistinguishable from those of patients with sporadic PD. However, some PD cases associated with LRRK2 mutations lack Lewy bodies (LBs), a neuropathological hallmark of PD.We investigated whether the presence or absence of LBs correlates with different clinical features in LRRK2-related PD. OBSERVATIONS: We describe genetic, clinical, and neuropathological findings of 37 cases of LRRK2-related PD including 33 published and 4 unpublished cases through October 2013.Among the different mutations, the LRRK2 p.G2019S mutation was most frequently associated with LB pathology. Nonmotor features of cognitive impairment/dementia, anxiety, and orthostatic hypotension were correlated with the presence of LBs. In contrast, a primarily motor phenotype was associated with a lack of LBs. CONCLUSIONS AND RELEVANCE: To our knowledge, this is the first report of clinicopathological correlations in a series of LRRK2-related PD cases. Findings from this selected group of patients with PD demonstrated that parkinsonian motor features can occur in the absence of LBs. However, LB pathology in LRRK2-related PD may be a marker for a broader parkinsonian symptom complex including cognitive impairment.

Original languageEnglish (US)
Pages (from-to)100-105
Number of pages6
JournalJAMA neurology
Volume72
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease'. Together they form a unique fingerprint.

Cite this